Docoh
Loading...

BLUE Bluebird bio

APP
Utility
CD79A Chimeric Antigen Receptors
26 Aug 21
The invention provides improved compositions for adoptive cell therapies for cancers that express CD79A.
Kevin FRIEDMAN, Molly Reed PERKINS
Filed: 14 Jun 19
APP
Utility
Anti-bcma Car Antibodies, Conjugates, and Methods of Use
26 Aug 21
The invention provides improved methods for detecting anti-BCMA CAR expression on T cells.
Kevin FRIEDMAN, Molly Reed PERKINS
Filed: 14 Jun 19
APP
Utility
Adoptive Cellular Therapy
19 Aug 21
The invention provides improved compositions and methods for the treatment of solid cancers.
James Brian ROTTMAN
Filed: 12 Apr 19
APP
Utility
NKG2D Daric Receptors
5 Aug 21
The present disclosure provides improved compositions for adoptive T cell therapies targeting NKG2D ligands for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
JORDAN JARJOUR, WAI-HANG LEUNG
Filed: 14 Dec 18
APP
Utility
Bruton's Tyrosine Kinase Homing Endonuclease Variants, Compositions, and Methods of Use
29 Jul 21
The present disclosure provides improved genome editing compositions and methods for editing a human BTK gene.
David J. RAWLINGS, Yupeng WANG, Iram F. KHAN, Joel GAY
Filed: 26 Apr 19
APP
Utility
CBLB Endonuclease Variants, Compositions, and Methods of Use
15 Jul 21
The present disclosure provides improved genome editing compositions and methods for editing a CBLB gene.
Jordan JARJOUR, Kyle HAVENS, Anne-Rachel KROSTAG
Filed: 15 Jan 21
APP
Utility
CBLB Endonuclease Variants, Compositions, and Methods of Use
15 Jul 21
The present disclosure provides improved genome editing compositions and methods for editing a CBLB gene.
Jordan JARJOUR, Kyle HAVENS, Anne-Rachel KROSTAG
Filed: 15 Jan 21
APP
Utility
Compounds for Improved Viral Transduction
10 Jun 21
The present invention provides methods and compositions for improving efficacy of viral transduction of cells.
Garrett Collins Heffner, Abraham Isaac Bassan
Filed: 17 Dec 20
GRANT
Utility
BCMA chimeric antigen receptors
1 Jun 21
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Richard Morgan, Kevin Friedman
Filed: 23 Oct 20
APP
Utility
CBLB Endonuclease Variants, Compositions, and Methods of Use
20 May 21
The present disclosure provides improved genome editing compositions and methods for editing a CBLB gene.
Jordan JARJOUR, Kyle HAVENS, Anne-Rachel KROSTAG
Filed: 25 May 18
APP
Utility
Bcma Chimeric Antigen Receptors
18 Mar 21
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Richard MORGAN, Kevin FRIEDMAN
Filed: 23 Oct 20
APP
Utility
Bcma Chimeric Antigen Receptors
18 Mar 21
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Richard MORGAN, Kevin FRIEDMAN
Filed: 23 Oct 20
APP
Utility
Bcma Chimeric Antigen Receptors
25 Feb 21
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Richard MORGAN, Kevin FRIEDMAN
Filed: 23 Oct 20
GRANT
Utility
CBLB endonuclease variants, compositions, and methods of use
23 Feb 21
The present disclosure provides improved genome editing compositions and methods for editing a CBLB gene.
Jordan Jarjour, Kyle Havens, Anne-Rachel Krostag
Filed: 25 Nov 19
APP
Utility
Bcma Chimeric Antigen Receptors
11 Feb 21
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Richard MORGAN, Kevin FRIEDMAN
Filed: 23 Oct 20
APP
Utility
PD-1 Homing Endonuclease Variants, Compositions, and Methods of Use
11 Feb 21
The present disclosure provides improved genome editing compositions and methods for editing a PD-1 gene.
Jasdeep MANN, Joel GAY, Jordan JARJOUR, Joy ZHANG
Filed: 8 Sep 17
APP
Utility
MND Promoter Chimeric Antigen Receptors
4 Feb 21
The invention provides vector compositions for delivering improved adoptive T cell therapies.
Richard MORGAN, Kevin FRIEDMAN, Byoung RYU
Filed: 7 Aug 20
GRANT
Utility
Compounds for improved viral transduction
2 Feb 21
The present invention provides methods and compositions for improving efficacy of viral transduction of cells.
Garrett Collins Heffner, Abraham Isaac Bassan
Filed: 28 Oct 19
APP
Utility
CTLA4 Homing Endonuclease Variants, Compositions, and Methods of Use
6 Jan 21
The present disclosure provides improved genome editing compositions and methods for editing a CTLA4 gene.
JORDAN JARJOUR, KYLE HAVENS
Filed: 19 Dec 18
APP
Utility
Daric Interleukin Receptors
16 Dec 20
The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
WAI-HANG LEUNG
Filed: 13 Dec 18
Patents are sorted by USPTO publication date, most recent first